Jeanne A. Thoma's most recent trade in ANI Pharmaceuticals Inc was a trade of 14,675 Common Stock done at an average price of $88.9 . Disclosure was reported to the exchange on Aug. 18, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
ANI Pharmaceuticals Inc | Jeanne A. Thoma | Director | Sale of securities on an exchange or to another person at price $ 88.87 per share. | 18 Aug 2025 | 14,675 | 23,405 (0%) | 0% | 88.9 | 1,304,167 | Common Stock |
ANI Pharmaceuticals Inc | Jeanne A. Thoma | Director | Sale of securities on an exchange or to another person at price $ 89.76 per share. | 18 Aug 2025 | 6,865 | 38,080 (0%) | 0% | 89.8 | 616,202 | Common Stock |
ANI Pharmaceuticals Inc | Jeanne A. Thoma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 4,336 | 44,945 (0%) | 0% | 0 | Common Stock | |
Avid Bioservices Inc | Jeanne A. Thoma | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2024 | 26,756 | 45,611 (0%) | 0% | - | Common Stock, $0.001 par value | |
Avid Bioservices Inc | Jeanne A. Thoma | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2024 | 26,756 | 0 | - | - | Restricted Stock Units | |
Avid Bioservices Inc | Jeanne A. Thoma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2024 | 8,147 | 8,147 | - | - | Restricted Stock Units |